UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004762
Receipt number R000005669
Scientific Title Clinical trial of preoperative chemoradiotherapy with TS-1 for locally advanced lower rectal cancer
Date of disclosure of the study information 2010/12/21
Last modified on 2013/12/27 11:03:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical trial of preoperative chemoradiotherapy with TS-1 for locally advanced lower rectal cancer

Acronym

preoperative chemoradiotherapy with TS-1 for rectal cancer

Scientific Title

Clinical trial of preoperative chemoradiotherapy with TS-1 for locally advanced lower rectal cancer

Scientific Title:Acronym

preoperative chemoradiotherapy with TS-1 for rectal cancer

Region

Japan


Condition

Condition

locally advanced lower rectal cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To clarify safety and efficacy of preoperative chemoradiothrapy with TS-1, surgical resection, combined with postoperative TS-1 treatment for T3-4 or N1 lower rectal cancer.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

3 year disease free survival rate

Key secondary outcomes

local recurrence rate, pathological effectiveness, down staging rate, anal preserving rate, total survival period, safety, treatment completing rate


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Maneuver

Interventions/Control_1

preoperative TS-1 treatment, preopeorative radiation, operation, postoperative TS-1 treatment

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) pathologically diagnosed as rectal adenocarcinoma
(2)located in lower rectum
(3)preoperative diagnosis; T3-T4 or T2N1-2
(4)no metastatic lesion
(5)ECOG performance status; 0-1
(6)age between 20-80
(7)no previous treatment for rectal cancer
(8)normal vital organ condition
(9)oral administration is available
(10)informed consent

Key exclusion criteria

(1)drug allergy
(2)active multi cancer
(3)contraindication of TS-1
(4)major complication
(5)interstitial pneumonia
(6)pleural effusion or ascites
(7)fresh gastrointestinal bleeding
(8)positive HBs antigen
(9)treating docter judged incompatible

Target sample size

35


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Nobuhiro Ohkohchi

Organization

University of Tsukuba, graduate school of comprehensive human sciences, clinical sciences

Division name

Organ Transplantation Gastroenterological and Hepatobiliary Surgery

Zip code


Address

Tennnodai 1-1-1, Tsukuba city, Ibaraki

TEL

029-853-3221

Email

nokochi3@md.tsukuba.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Soichiro Murata

Organization

University of Tsukuba, graduate school of comprehensive human sciences, clinical sciences

Division name

Organ Transplantation Gastroenterological and Hepatobiliary Surgery

Zip code


Address

Tennnodai 1-1-1, Tsukuba city, Ibaraki

TEL

029-853-3221

Homepage URL


Email

soichiro@md.tsukuba.ac.jp


Sponsor or person

Institute

University of Tsukuba

Institute

Department

Personal name



Funding Source

Organization

self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

筑波大学附属病院(茨城県)


Other administrative information

Date of disclosure of the study information

2010 Year 12 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2010 Year 12 Month 21 Day

Date of IRB


Anticipated trial start date

2010 Year 12 Month 01 Day

Last follow-up date

2015 Year 11 Month 01 Day

Date of closure to data entry

2015 Year 12 Month 01 Day

Date trial data considered complete

2015 Year 12 Month 01 Day

Date analysis concluded

2016 Year 03 Month 01 Day


Other

Other related information



Management information

Registered date

2010 Year 12 Month 21 Day

Last modified on

2013 Year 12 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005669


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name